Literature DB >> 20849079

Active metalloproteases of the A Disintegrin and Metalloprotease (ADAM) family: biological function and structure.

Theo Klein1, Rainer Bischoff.   

Abstract

The "a disintegrin and metalloproteases" (ADAMs) are membrane-anchored metzincins of the adamalysin subfamily. This review gives an overview over the biological function and structure of ADAMs focusing on members of the family that display proteolytic activity. ADAMs are involved in a range of human diseases such as cancer metastasis, inflammatory disorders, neurological disease or asthma. It is, however, often difficult to assign a definitive role to a specific member of the ADAM family in a given disease mechanism due to overlapping activities and redundancy in function, as shown in various knock-out studies. The review discusses the structural domains that are not directly linked to protease activity followed by a more detailed overview over the role of the metalloprotease domain. Different family members are critically reviewed with respect to their role in biological processes with particular emphasis on disease-relevant functions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20849079     DOI: 10.1021/pr100556z

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  80 in total

1.  Salt-Mediated Nanopore Detection of ADAM-17.

Authors:  Xiaohan Chen; Youwen Zhang; Golbarg Mohammadi Roozbahani; Xiyun Guan
Journal:  ACS Appl Bio Mater       Date:  2018-12-24

2.  Vascular Pathology as a Potential Therapeutic Target in SCI.

Authors:  Richard L Benton; Theo Hagg
Journal:  Transl Stroke Res       Date:  2011-11-29       Impact factor: 6.829

3.  Regulated ADAM17-dependent EGF family ligand release by substrate-selecting signaling pathways.

Authors:  Michelle Dang; Nicole Armbruster; Miles A Miller; Efrain Cermeno; Monika Hartmann; George W Bell; David E Root; Douglas A Lauffenburger; Harvey F Lodish; Andreas Herrlich
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-29       Impact factor: 11.205

4.  ADAMDEC1 is a metzincin metalloprotease with dampened proteolytic activity.

Authors:  Jacob Lund; Ole H Olsen; Esben S Sørensen; Henning R Stennicke; Helle H Petersen; Michael T Overgaard
Journal:  J Biol Chem       Date:  2013-06-10       Impact factor: 5.157

Review 5.  Metalloproteinases and their natural inhibitors in inflammation and immunity.

Authors:  Rama Khokha; Aditya Murthy; Ashley Weiss
Journal:  Nat Rev Immunol       Date:  2013-09       Impact factor: 53.106

6.  Proteolytic processing of the prion protein in health and disease.

Authors:  Hermann C Altmeppen; Berta Puig; Frank Dohler; Dana K Thurm; Clemens Falker; Susanne Krasemann; Markus Glatzel
Journal:  Am J Neurodegener Dis       Date:  2012-05-15

7.  An optimized isolation of biotinylated cell surface proteins reveals novel players in cancer metastasis.

Authors:  Piia-Riitta Karhemo; Suvi Ravela; Marko Laakso; Ilja Ritamo; Olga Tatti; Selina Mäkinen; Steve Goodison; Ulf-Håkan Stenman; Erkki Hölttä; Sampsa Hautaniemi; Leena Valmu; Kaisa Lehti; Pirjo Laakkonen
Journal:  J Proteomics       Date:  2012-07-17       Impact factor: 4.044

Review 8.  Architecture and function of metallopeptidase catalytic domains.

Authors:  Núria Cerdà-Costa; Francesc Xavier Gomis-Rüth
Journal:  Protein Sci       Date:  2014-02       Impact factor: 6.725

9.  Identification and characterization of promoter and regulatory regions for mouse Adam2 gene expression.

Authors:  Heejin Choi; Boyeon Lee; Sora Jin; Jun Tae Kwon; Jihye Kim; Juri Jeong; Seungmin Oh; Byung-Nam Cho; Zee Yong Park; Chunghee Cho
Journal:  Mol Biol Rep       Date:  2012-10-12       Impact factor: 2.316

Review 10.  TSH Receptor Cleavage Into Subunits and Shedding of the A-Subunit; A Molecular and Clinical Perspective.

Authors:  Basil Rapoport; Sandra M McLachlan
Journal:  Endocr Rev       Date:  2016-02       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.